Volume No. :   2

Issue No. :  4

Year :  2010

ISSN Print :  0975-4407

ISSN Online :  2321-5836


Allready Registrered
Click to Login

New Frontiers on Hyperlipidemia in Pharmaceutical Education

Address:   L.K. Kanthal*, P. Mondal, D. Saha, D. Mridha and S. Mandal
Bharat Technology, Banitabla, Uluberia, Howrah, W.B. India.
*Corresponding Author
DOI No: Not Available

The condition of hyperlipidemia can be described as high cholesterol in the blood (hypercholesterolemia), high triglycerides in the blood (hypertriglyceridemia) or it could be both. Hyperlipidemia is a major risk factor in the initiation and progression of atherosclerotic lesions, conditions such as coronary heart disease, ischemic cerebrovascular disease and peripheral vascular disease which leads high morbidity rate in developed countries. The present article gives different classes of anti-hyperlipidemics highlighting the pathophysiology of artherosclerosis, classification, side effects and therapeutic uses of antihyperlipidemics.
Hyperlipidemia, cholesterol, atherosclerotic blood vessel
L.K. Kanthal, P Mondal, D Saha, D Mridha, S Mandal. New Frontiers on Hyperlipidemia in Pharmaceutical Education. Research J. Pharmacology and Pharmacodynamics. 2010; 2(4): 257-260.
[View HTML]      [View PDF]

Visitor's No. :   232590